Clinical Trials Directory

Trials / Sponsors / Cancer Advances Inc.

Cancer Advances Inc.

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
CompletedSequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer
Pancreatic Cancer
Phase 32001-04-01
CompletedPhase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma
Colorectal Cancer
Phase 22001-03-01
CompletedSafety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced
Pancreatic Cancer
Phase 32001-02-01
CompletedStudy to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
Gastric Cancer
Phase 22001-02-01
CompletedAn Open Label Study to Evaluate G17DT Compared to Gemcitabine
Pancreatic Cancer
Phase 32000-08-14
CompletedSafety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
Stomach Neoplasms, Esophageal Neoplasms
Phase 22000-08-01
CompletedTwo Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.
Colorectal Cancer
Phase 22000-07-01
CompletedEffect of G17DT in Patients With Stage II/III Colorectal Cancer
Colorectal Cancer
Phase 22000-04-01
CompletedStudy to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer
Gastric Cancer
Phase 22000-02-01
CompletedOpen-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Canc
Gastric Cancer
Phase 21999-08-01
CompletedSingle Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Jaundice, Pancreatic Cancer
Phase 21999-08-01
CompletedAn Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability
Pancreatic Cancer
Phase 21999-04-01
CompletedDose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Gastric Cancer
Phase 21998-09-01
TerminatedA Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer
Colorectal Cancer
Phase 21994-05-01
CompletedStudy to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.
Colorectal Cancer
Phase 21993-10-01